The long-term growth drivers of Accenture stock are expected to be the prime topic at the company's investor day on Thursday. But analysts don't expect updated financial guidance for ACN stock.
Accenture shares have retreated 17% in 2022.
"ACN will host its first investor & and analyst day since 2018," said Susquehanna analyst James Friedman in a report. "We anticipate the I&A day to be more strategic and less financial."
He added: "At the same time, we believe a question on many investors' minds is, how Accenture might redefine its TAM (total addressable market."
The global tech consulting and services company reported fiscal second-quarter earnings on March 17 that topped estimates.
Morgan Stanley analyst James Faucette in a report said the investor day could lift ACN stock if management provides "qualitative commentary around drivers of longer-term growth."
ACN Stock: No Let Up In Acquisitions
"While we do not expect an explicit multiyear outlook at this week's conference, we see the opportunity for management to provide meaningful context around the potential for structurally faster growth vs. pre-pandemic levels."
Meanwhile, Accenture continues to make acquisitions to move into digital, cloud computing, cybersecurity and artificial intelligence. The company has earmarked roughly $4 billion for acquisitions in fiscal 2021 and 2022.
"This week's conference marks the first time CEO Julie Sweet and CFO KC McClure have addressed the investment community in this type of forum since assuming their respective roles, with the company's last (investor day) in April 2018," Faucette said.
Heading into the investor day, ACN stock has an IBD Relative Strength Rating of 76, according to IBD Stock Checkup.
If you're new to IBD, consider taking a look at its stock trading system and CAN SLIM basics. Recognizing chart patterns is one key to the investment guidelines.
Follow Reinhardt Krause on Twitter @reinhardtk_tech for updates on 5G wireless, artificial intelligence, cybersecurity and cloud computing.
